Insys Founder, Six Officials Face Charges of Fraud Over Fentanyl-based Cancer Drug

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Insys Founder, Six Officials Face Charges of Fraud Over Fentanyl-based Cancer Drug

Ken Baumgartner

October 31, 2017 at 14:19:00 ET

The U.S. Department of Justice announced Oct. 26 the indictments of the founder and majority owner of Insys Therapeutics and six former executives for causing the illegal distribution of a fentanyl spray drug intended for cancer patients experiencing breakthrough pain. Insys founder John N. Kapoor of Phoenix, Arizona, and the other individuals have been charged with RICO conspirac... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Insys Founder, Six Officials Face Charges of Fraud Over Fentanyl-based Cancer Drug

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT